Biologos News

Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”).

Biologos will exhibit at the 2022 AATB Annual Meeting from September 3rd – September 24th at the Gaylord Rockies Resort & Convention Center.

INTERPHEX NYC 2024 — Uniting industry professionals from pharmaceutical, biotech and device facilities and more. Leading global event that fuses industry innovation with expert-led technical conference.

ISIA’s mission is to “establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal-derived products supply industry.”

ISIA’s mission is to “establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal-derived products supply industry.”

The Biologos team is looking forward to attending the ISPE Boston Area Chapter Product Show. Come see us at the Gillette Stadium on September 21st at booth #W85!

Biologos stands out as the biological brand trusted by more than 90 percent of U.S.-based tissue processing facilities, as well as the eight largest animal health companies in the U.S.!

We can’t wait to see many of our new partners and expand our knowledge in cell and gene therapy!

Thank you to everyone who came to visit us.

Biologos stands out as the biological brand trusted by more than 90 percent of U.S. based tissue processing facilities, as well as the eight largest animal health companies in the U.S.!